| Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a … M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ... The Lancet 394 (10214), 2096-2107, 2019 | 618* | 2019 |
| Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers JM Clayton, KM Hancock, PN Butow, MHN Tattersall, DC Currow The Medical Journal of Australia 186 (12), S77, 2007 | 475 | 2007 |
| Ethics and law for the health professions I Kerridge, M Lowe, C Stewart Federation Press, 2009 | 376 | 2009 |
| Ethics and evidence based medicine I Kerridge, M Lowe, D Henry Bmj 316 (7138), 1151-1153, 1998 | 273 | 1998 |
| Uniform format for disclosure of competing interests in ICMJE journals JM Drazen, MB Van Der Weyden, P Sahni, J Rosenberg, A Marusic, ... The Lancet 374 (9699), 1395-1396, 2009 | 244 | 2009 |
| Advance care planning for cancer patients: a systematic review of perceptions and experiences of patients, families, and healthcare providers S Johnson, P Butow, I Kerridge, M Tattersall Psycho‐oncology 25 (4), 362-386, 2016 | 229 | 2016 |
| Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era … B George, N Pati, N Gilroy, M Ratnamohan, G Huang, I Kerridge, ... Transplant infectious disease 12 (4), 322-329, 2010 | 208 | 2010 |
| Interprofessionalism and ethics: consensus or clash of cultures? R Irvine, I Kerridge, J McPhee, S Freeman Journal of Interprofessional Care 16 (3), 199-210, 2002 | 191 | 2002 |
| Evidence, ethics, and values: a framework for health promotion SM Carter, L Rychetnik, B Lloyd, IH Kerridge, L Baur, A Bauman, ... American journal of public health 101 (3), 465-472, 2011 | 185 | 2011 |
| Death, dying and donation: organ transplantation and the diagnosis of death IH Kerridge, P Saul, M Lowe, J McPhee, D Williams Journal of medical ethics 28 (2), 89-94, 2002 | 166 | 2002 |
| Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry PA Komesaroff, IH Kerridge Medical Journal of Australia 176 (3), 118-121, 2002 | 146 | 2002 |
| Implementing a One Health approach to emerging infectious disease: reflections on the socio-political, ethical and legal dimensions C Degeling, J Johnson, I Kerridge, A Wilson, M Ward, C Stewart, G Gilbert BMC Public Health 15, 1-11, 2015 | 138 | 2015 |
| A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia SZ He, S Busfield, DS Ritchie, MS Hertzberg, S Durrant, ID Lewis, ... Leukemia & lymphoma 56 (5), 1406-1415, 2015 | 134 | 2015 |
| Association between xenobiotic gene polymorphisms and non‐Hodgkin's lymphoma risk I Kerridge, L Lincz, F Scorgie, D Hickey, N Granter, A Spencer British journal of haematology 118 (2), 477-481, 2002 | 125 | 2002 |
| Selection of medical students according to their moral orientation M Bore, D Munro, I Kerridge, D Powis Medical education 39 (3), 266-275, 2005 | 106 | 2005 |
| Specific unwillingness to donate eyes: the impact of disfigurement, knowledge and procurement on corneal donation M Lawlor, I Kerridge, R Ankeny, TA Dobbins, F Billson American Journal of Transplantation 10 (3), 657-663, 2010 | 99 | 2010 |
| Withdrawal and limitation of life‐sustaining treatments in a paediatric intensive care unit and review of the literature P Moore, I Kerridge, J Gillis, S Jacobe, D Isaacs Journal of paediatrics and child health 44 (7‐8), 404-408, 2008 | 93 | 2008 |
| Caring for young people with cancer: practical implications of qualitative engagement with cancer survivors and members of the multidisciplinary team P Lewis, J Mooney-Somers, P Patterson, CFC Jordens, D Bennett, ... Australian Journal of Cancer Nursing, The 15 (2), 39-42, 2014 | 89 | 2014 |
| Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy CE Nath, PJ Shaw, J Trotman, L Zeng, SB Duffull, G Hegarty, ... British journal of clinical pharmacology 69 (5), 484-497, 2010 | 87 | 2010 |
| An international comparison of the effect of policy shifts to organ donation following cardiocirculatory death (DCD) on donation rates after brain death (DBD) and … A Bendorf, PJ Kelly, IH Kerridge, GW McCaughan, B Myerson, C Stewart, ... PloS one 8 (5), e62010, 2013 | 86 | 2013 |
